Navigation Links
Martek Announces Fourth Quarter and FY 2008 Financial Results
Date:12/11/2008

on and $89 million with first quarter infant formula revenue projected to be between $74 million and $77 million and first quarter non-infant formula nutritional revenue projected to be between $7 million and $8.5 million. First quarter gross margin is expected to be approximately 42.5%. Net income for the first quarter is projected to be between $8.7 million and $9.7 million, and diluted earnings per share are projected to be between $0.27 and $0.29.

With respect to fiscal 2009, the Company expects moderate growth of both revenues and profitability over fiscal 2008 with profitability growing at a higher rate than revenues primarily due to improvements in gross profit margins; however, a deep, prolonged economic recession would yield additional uncertainty with respect to the Company's attainment of its forecasted operating results.

Reconciliation of GAAP to Non-GAAP Net Income Measure

The Company makes reference in this release to non-GAAP presentations of net income and earnings per share that exclude certain non-recurring tax benefits and restructuring charge. We are providing this information to assist investors in comparing the results of the current period to those in the prior year periods when the non-recurring items were not present. We caution investors, however, that these non-GAAP results should only be considered in addition to results that are reported under current GAAP and should not be considered as a substitute for results that are presented under GAAP. Following is a schedule showing the reconciliation of net income reported under GAAP to the non-GAAP financial measure included herein ($ in thousands):



                                         Three months ended     Year ended
                                            October 31,         October 31,
                                          2008       2007     2008     2007

    Net income, as reported under GAAP 
'/>"/>
SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Martek Announces Fourth Quarter and FY 2007 Financial Results
9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 Research ... addition of Jain PharmaBiotech,s new report  "Alzheimer ...  to their offering.       (Logo: ... challenge in management. With nearly 8 million ... major markets of the world and anticipated ...
(Date:5/28/2015)... , May 28, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/8h5hs2/animal ) has announced the addition ... Biotechnology - Technologies, Markets and Companies" ... , ,This report describes and evaluates ... veterinary medicine and pharmaceuticals as well ...
(Date:5/28/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/6cg3zw/cell_therapy ) ... report "Cell Therapy - Technologies, Markets and ... report describes and evaluates cell therapy technologies and ... important role in the practice of medicine. Hematopoietic ... bone marrow transplants. Role of cells in drug ...
(Date:5/28/2015)... May 28, 2015 Celsion Corporation (the "Company") ... received commitments from two institutional healthcare investors to purchase ... common stock in an at-the-market registered direct offering and ... stock. The Company entered into a definitive ... Company agreed to sell an aggregate of 3,000,000 shares ...
Breaking Biology Technology:Global Alzheimer Disease Report 2015-2024 - New Drugs, Markets and Companies 2Global Alzheimer Disease Report 2015-2024 - New Drugs, Markets and Companies 3Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 2Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 3Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 3
... N.Y. and BERLIN, June 28, 2011 ... HealthCare today announced that Bayer Yakuhin, Ltd., ... of Health, Labor and Welfare (MHLW) in Japan for ... for the treatment of the neovascular form of age-related ...
... Hollywood celebrities, the term "splitsville" usually means "check ... quality nanoribbons from boron nitride nanotubes, "splitsville" could ... Lawrence Berkeley National Laboratory (Berkeley Lab) and the ... at Rice University, have developed a technique in ...
... 28, 2011 The PleuraFlow™ Active Tube Clearance™ System has ... Annual R&D 100 Awards, which salute the 100 most technologically ... A full list of this year,s winners is available at ... winning a 2011 MDEA Gold award, as well as ID ...
Cached Biology Technology:EYLEA™ (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration 2EYLEA™ (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration 3EYLEA™ (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration 4EYLEA™ (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration 5EYLEA™ (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration 6Splitsville for boron nitride nanotubes 2Splitsville for boron nitride nanotubes 3Splitsville for boron nitride nanotubes 4PleuraFlow Captures Prestigious Innovation Award 2PleuraFlow Captures Prestigious Innovation Award 3PleuraFlow Captures Prestigious Innovation Award 4
(Date:4/27/2015)... 2015  For more than four decades, AUVSI,s ... the premier worldwide event for the unmanned land, sea, ... event for any local, national, or trade news organization ... markets and current applications of unmanned technologies. The conference ... $48 billion industry, and how it will soon impact ...
(Date:4/20/2015)... -- The announcement comes as demand for ... (GRM), Ireland,s foremost records management company, ... up an impressive track record of clients within the first ... records management sector in Dubai . As ... and employ a further eight staff members at its Irish ...
(Date:4/13/2015)... CHICAGO , April 13, 2015  higi, a ... with ways to more fully engage with their communities ... its industry-leading, privacy protected and secure API.  ... API enables the most accessible, affordable, and convenient vehicle ... The API will ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... a public/private partnership dedicated to developing, advancing, and ... challenges, today announced three winning solutions in the ... open innovation challenge. Solvers located in New Zealand, ... prize for their innovative ideas for developing significantly ...
... (March 28, 2011) University of Kentucky plant pathologists recently ... in the ability of plants, animals, humans and one-celled microorganisms ... cellular level, which is known as systemic immunity. This mode ... but the key events that stimulate that resistance have remained ...
... pathogens cause diseases in plants remains a mystery and ... Now Wenbo Ma , a young plant ... research on the soybean plant in the lab that ... a rapidly developing area among the plant sciences. ...
Cached Biology News:Scientists Without Borders awards $10,000 to solvers of maternal health and nutrition challenge 2Scientists Without Borders awards $10,000 to solvers of maternal health and nutrition challenge 3Kentucky researchers find a key to plant disease resistance 2How do plants fight disease? 2How do plants fight disease? 3
RABBIT ANTI QUINOLINIC ACID...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
... MagCellect Ferrofluid products perform optimally ... R&D Systems MagCellect Magnet. To ... neodymium iron boron permanent magnet ... 75 mm test tubes or ...
Request Info...
Biology Products: